Association of Previous Myocardial Infarction and Time to Presentation With Suspected Acute Myocardial Infarction - Troester, V.; Strebel, I.; Nestelberger, T.; Boeddinghaus, J.; Rubini Gimenez, M.; Lopez-Ayala, P.; Koechlin, L.; Glarner, N.; Prepoudis, A.; Miro, O.; Martin-Sanchez, F. J.; Kawecki, D.; et al. (J Am Heart Assoc, 2020)
Keywords: journalArticle; *Chest Pain/blood/diagnosis/etiology/psychology; *Myocardial Infarction/blood/diagnosis/physiopathology/psychology; Adult; Amgen, Astra Zeneca, Boehringer Ingelheim, Bayer, BMS, Idorsia, Novartis, Osler,; Bangerter-Rhyner Foundation, as well as the "Freiwillige Akademische Gesellschaft; Bangerter-Rhyner-Foundation; Basel." Dr Rubini has received research grants from the Swiss Heart Foundation; Biomarkers/blood; Biomerieux, Idorsia, Ortho Cinical Diagnostics, Quidel, Roche, Siemens, Singulex,; Cardiology, the University Hospital of Basel, the University of Basel, and the; Cardiovascular Research Foundation Basel as well as speaker honoraria/consulting; Corporation. Dr Koechlin received a research grant from the University of Basel,; Coulter, Bayer, Ortho Clinical Diagnostics, and Orion Pharma, outside the; Delayed Diagnosis/*prevention & control; Dr Twerenbold received research support from the Swiss National Science; Early Medical Intervention/methods/standards; Europe/epidemiology; European Union, the University of Basel, the University Hospital Basel, the; Female; Foundation (P300PB_167803), the Swiss Heart Foundation, the Swiss Society of; Foundation (P400PM_191037/1), the Prof. Dr. Max Cloetta Foundation, the Margarete; Health Knowledge, Attitudes, Practice; Help-Seeking Behavior; Humans; Male; Medical History Taking/methods; Myocardial Revascularization/methods/statistics & numerical data; Patient Education as Topic/*methods; Roche, and Sanofi, outside of the submitted work. The remaining authors have no; Stiftung fur kardiovaskulare Forschung Basel, Abbott, Beckman Coulter,; Swiss Heart Foundation, Swiss Commission for Technology and Innovation, the; Time-to-Treatment/*standards; Troponin I/*blood; acute coronary syndrome; and Sphingotec, as well as speaker honoraria/consulting honoraria from Acon,; and Swiss National Science Foundation (P400PM_180828) as well as; and has received speaker honoraria and/or consulting; disclosures to report; education; has received research support from the Swiss National Science Foundation, the; honoraria from Abbott, Amgen, Brahms, Roche, Singulex, and Siemens. Dr Mueller; honoraria from Siemens, Roche Diagnostics, Ortho Clinical Diagnostics, and Quidel; of Basel, the University Hospital of Basel, the Division of Internal Medicine,; prevention; secondary prevention; speakers/consulting honoraria from Abbott, Ortho Diagnostic, Roche, and Siemens; submitted work. Dr Boeddinghaus has received research grants from the University; the Swiss Academy of Medical Sciences, and the Gottfried and Julia; und Walter Lichtenstein-Stiftung (3MS1038), and the University Hospital Basel as; well as speaker honoraria/consulting honoraria from Siemens, B. Braun, Beckman